Acceleron Pharma
XLRN
#1840
Rank
NZ$18.71 B
Marketcap
NZ$305.97
Share price
0.00%
Change (1 day)
14,544.90%
Change (1 year)

Market capitalization of Acceleron Pharma (XLRN)

Last known market cap: NZ$18.71 Billion

As of December 2025 Acceleron Pharma has a market cap of NZ$18.71 Billion. This makes Acceleron Pharma the world's 1840th most valuable company by market cap according to our data. The market capitalization, commonly called market cap, is the total market value of a publicly traded company's outstanding shares and is commonly used to measure how much a company is worth.

Market cap history of Acceleron Pharma from 2013 to 2022

End of year Market Cap

Year Marketcap Change
2022NZ$17.21 B7.58%
2021NZ$16.00 B49.8%
2020NZ$10.68 B155.45%
2019NZ$4.18 B39.24%
2018NZ$3.00 B11.11%
2017NZ$2.70 B94.38%
2016NZ$1.39 B-41.41%
2015NZ$2.37 B47.17%
2014NZ$1.61 B18.05%
2013NZ$1.36 B

Market capitalization for similar companies or competitors

Name Marketcap Market cap differencediff. Country
Amgen
AMGN
NZ$307.81 B 1,545.06%๐Ÿ‡บ๐Ÿ‡ธ USA
Regeneron Pharmaceuticals
REGN
NZ$142.17 B 659.85%๐Ÿ‡บ๐Ÿ‡ธ USA
Johnson & Johnson
JNJ
NZ$856.88 B 4,479.42%๐Ÿ‡บ๐Ÿ‡ธ USA
Onconova Therapeutics
ONTX
NZ$35.78 M-99.81%๐Ÿ‡บ๐Ÿ‡ธ USA
Sangamo Therapeutics
SGMO
NZ$0.25 B-98.63%๐Ÿ‡บ๐Ÿ‡ธ USA
bluebird bio
BLUE
NZ$83.3 M-99.55%๐Ÿ‡บ๐Ÿ‡ธ USA
Pfizer
PFE
NZ$243.59 B 1,201.85%๐Ÿ‡บ๐Ÿ‡ธ USA